Bortezomib successfully reduces monoclonal serum free light chain levels in a patient with recurrent myeloma and cast nephropathy in the renal transplant.
| Autor: | Kumar V; Dept of Medicine, Division of Nephrology and Transplant, University of Alabama at Birmingham, USA., Elkins S, Gaston RS, Prendergast MB, Reddy V, Cook WJ, Sanders PW |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical transplants [Clin Transpl] 2009, pp. 439-41. |
| Abstrakt: | Bortezomib can be used to successfully treat acute kidney injury in the renal transplant allograft due to light chain cast nephropathy from recurrent multiple myeloma. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|